Latest From Biotech Now

Herbicides and 2, 4-D: Cutting Through the Controversy

admin-ajax (2)

A number of media outlets reported on last week’s decision by the USDA to approve the use of genetically modified corn and soybean seeds that are resistant to the herbicide known as 2, 4-D. Farmers and growers, anxious for new tools in the ever-evolving fight against weeds, have been long awaiting the approval. The American Soybean Association, for example, issued a statement cheering the move and calling on the Environmental Protection Agency (EPA) to now Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Investment in NJ Biotech is Way Up

graph

Total funding of New Jersey life sciences companies spiked in 2013 with approximately $900 million in both early and late-stage investments, according to a new report from BioNJ. This figure represents well over 200 percent growth over the prior year. Funding was helped by seven New Jersey companies that completed initial public offerings (IPOs) in 2013. Furthermore, industry wages averaged $126,794 in 2012, led by pharmaceuticals ($137,949), followed by biotechnology ($132,576) and medical devices ($94,652). Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

GMO Answers Provides an Overview of GMOs in Medicine

GMO Answers

With genetically engineered therapies for the infectious disease, Ebola, currently undergoing testing for safety and efficacy, GMO Answers is highlighting the use of genetic engineering in other biomedical applications. The post’s author, Richard Green, also looks at why GMOs, though used in both agriculture and medicine, are more controversial in agricultural applications. The technology of genetic modification or genetic engineering was first developed in the early 1970s, commercialized in pharmaceutical applications in the early 1980s, and then agricultural Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

San Francisco Chronicle: High Drug Co-Pays Deny Needed Treatments

Jim Greenwood

Today, the San Francisco Chronicle published an op-ed that I wrote on the importance of ensuring access to treatments for debilitating diseases that are saving millions of patients from pain and possible death. Patients rightly expect their health insurance plan to cover the best medicines based on their unique needs, at an out-of-pocket cost that makes these therapies accessible. Insurance companies and their allies, seeking to deflect blame for increased premiums at a time of Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Jim Murray Closes BIO LBS with Memorable Keynote

LBS-graphic-200x100 copy

“We need to learn how to feed the world better,  We cannot feed the world using organic or hunter-gatherer technologies.” – Dr. Jim Murray In his closing Keynote, Dr. James Murray, Professor Animal Science and Population Health at the University of California at Davis reminded attendees how vital animal biotechnology will be in helping to feed a rapidly growing population. Dr. Murray opened by commenting that one child dies every 5 seconds because of hunger. “This Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,